Saltar al contenido
Merck

14380C

SAFC

EX-CELL® CD Insect Cell Medium

Chemically defined, sterile-filtered, suitable (for insect cell culture)

Fabricación farmacéutica

Iniciar sesiónpara Ver la Fijación de precios por contrato y de la organización


About This Item

UNSPSC Code:
12352207

Quality Level

sterility

sterile-filtered

product line

EX-CELL®

form

liquid

technique(s)

cell culture | insect: suitable

components

NaHCO3: no
L-glutamine: yes

shipped in

ambient

storage temp.

2-8°C

General description

EX-CELL® CD Insect Cell Medium can be used as amplification and production medium for Spodoptera frugiperda (Sf) cells such as Sf21 and Sf9 cells and is compatible with Tni, C636 and S2 cells. The medium has been optimized to get excellent growth and productivity for the rhabdovirus-free Sf-RVN Insect Cell Line(Sf9). Together those products form the Sf-RVN Platform. The formulation is chemically defined, animal-component free and has been formulated with L-Glutamine.

Legal Information

EX-CELL is a registered trademark of Merck KGaA, Darmstadt, Germany
Sf-RVN is a trademark of Merck KGaA, Darmstadt, Germany

Storage Class

12 - Non Combustible Liquids

wgk_germany

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable


Certificados de análisis (COA)

Busque Certificados de análisis (COA) introduciendo el número de lote del producto. Los números de lote se encuentran en la etiqueta del producto después de las palabras «Lot» o «Batch»

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos

Los clientes también vieron

Artículos

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

The current status and future manufacturing of AAV-based gene therapies is discussed in this podcast transcript, including how to streamline large-scale manufacturing.

Minimize the complexities of cell and gene therapy production. Switch to upstream viral vector platforms to enhance scalability and simplify GMP manufacturing.

Ver todo

Nuestro equipo de científicos tiene experiencia en todas las áreas de investigación: Ciencias de la vida, Ciencia de los materiales, Síntesis química, Cromatografía, Analítica y muchas otras.

Póngase en contacto con el Servicio técnico